-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new coronary pneumonia not only poses a challenge to the health care system around the world, but also causes great disruption to the daily lives of many people
.
Therefore, preventing the spread of the new coronavirus has become the main goal of pandemic management
The new coronary pneumonia not only poses a challenge to the health care system around the world, but also causes great disruption to the daily lives of many people
This study aims to investigate the changes in SARS-CoV-2-Ab levels in PLWH after standard vaccination at the HIIV Center in Munich, Germany, and to investigate the relationship between general and HIV-specific factors and the development of SARS-CoV-2
.
Researchers conducted a retrospective analysis of the electronic patient files of a large single HIV center in Munich, Germany
.
Nonparametric variables are used for descriptive and comparative statistics
The results of the study showed that a total of 665 HIV-infected persons were included in the analysis (median age: 53 [IQR: 43; 59]), and 560 patients were men
.
The median concentration of anti-SARS-CoV-2 antibody is 1400 (IQR 664; 2130) BAU/mL
This study confirmed that there was a strong antibody response in HIV-infected people who received standard vaccination against SARS-CoV-2
.
When the patient receives mRNA vaccination, and the patient is female and the CD4 cell count is higher, the higher antibody concentration of HIV-infected persons is related
This study confirmed that there was a strong antibody response in HIV-infected people who received standard vaccination against SARS-CoV-2
Original source:
Sebastian Noe.
Humoral response to SARS-CoV-2 vaccines in people living with HIV.
Leave a message here